The cardiovascular morbidity and mortality are increased in rheumatoid arthritis and probably equal those of patients with type 2 diabetes mellitus. The European League Against Rheumatism has recently provided evidence-based guidelines for cardiovascular risk management in patients with rheumatoid arthritis and we here briefly summarise these guidelines and other recent data in this area of research.